Articles
-
1 month ago |
optometrytimes.com | Melissa Tawa |Cecelia Koetting |Melissa Barnett |Deborah Ristvedt |Jordana Joy
The rustic landscape of Napa Valley hosted CRU 2025, which allowed optometrists and ophthalmologists to learn the latest in glaucoma, retina, and more. In between wine tastings, eye care providers had the chance to reflect on what they are taking back to their practices that is current, relevant, and useful. Melissa Tawa, OD, FAAO, highlighted what she learned about inherited retinal diseases at the conference.
-
1 month ago |
optometrytimes.com | Melissa Barnett |Jordana Joy
In their presentation "Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes," Melissa Barnett, OD, FAAO, FSLS, FBCLA; Cecelia Koetting, OD, FAAO, DipABO; Jennifer Li, MD; and Quan Đông Nguyễn, MD, MSc, emphasized the importance of corneal sensitivity testing before any anesthetics, considering various conditions like preservatives, artificial tears, and eye surgeries that can lead to neurotrophic keratitis (NK).
-
1 month ago |
optometrytimes.com | Melissa Barnett |Jordana Joy
March 30, 2025By Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025. Melissa Barnett, OD, FAAO, FSLS, FBCLA, director of optometry at University of California Davis, discusses keratoconus diagnosis, management, and key insights in a presentation given alongside John D. Gelles, OD, FIAO, FCLSA, FSLS, FBCLA, at CRU 2025. In an interview with Optometry Times, she emphasizes early detection as critical for effective treatment.
-
Nov 29, 2024 |
optometrytimes.com | Melissa Barnett |Emily Kaiser Maharjan |Jordana Joy
November 29, 2024By Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS. Melissa Barnett, OD, FAAO, FSLS, discussed a real-world study on eye care professional and patient satisfaction with the dry eye treatment lifitegrast (Xiidra) at this year's American Academy of Optometry meeting.
-
Nov 15, 2024 |
reviewofoptometry.com | Melissa Barnett |Madison Bailey
All sorts of medications cause ophthalmic side effects and can affect specific anatomical structures of the eye. A common example is hydroxychloroquine, which causes a dose-related maculopathy when it accumulates in the maculae.1 Medications can similarly accumulate in the cornea and it’s our responsibility as clinicians to be vigilant and responsive when it happens.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →